David N. Wald

3.8k citations
83 papers · 2.3k indexed · h-index 23
Topics
Acute Myeloid Leukemia Research (22 papers)Immune Cell Function and Interaction (19 papers)CAR-T cell therapy research (16 papers)
Partner nations
United StatesChinaCanada

In The Last Decade

David N. Wald

74 papers receiving 2.3k citations

Peers

David N. Wald
Comparison fields: 5 of 116
  • Immunology 1.2k
  • Molecular Biology 907
  • Oncology 557
  • Cancer Research 350
  • Hematology 318
Replace Zhixing K. Pan with:
Zhixing K. Pan United States
Hun Sik Kim South Korea
Masaki Suemura Japan
Rao Prabhala United States
Takeshi Otsuka Japan
Brian W. Wong United States
Mohamed Hassan Germany
Brian K. Dieckgraefe United States
Kunzo Orita Japan
David N. Wald relative to Zhixing K. Pan United States Zhixing K. Pan's profile →
Citations per field
00.5×
Zhixing K. Pan · 1×
Citations per year

Countries citing papers authored by David N. Wald

Since Specialization
Citations

This map shows the geographic impact of David N. Wald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N. Wald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N. Wald more than expected).

Fields of papers citing papers by David N. Wald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N. Wald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N. Wald. The network helps show where David N. Wald may publish in the future.

Co-authorship network of co-authors of David N. Wald

This figure shows the co-authorship network connecting the top 25 collaborators of David N. Wald. A scholar is included among the top collaborators of David N. Wald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N. Wald. David N. Wald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 2
5 52
6 16
7 35
8 9
9 110
10 35
11 17
12 39
13 35
14 9
15 11
16 63
17 52
18 46
19 2
20 1

About David N. Wald

David N. Wald is a scholar working on Hematology, Immunology and Oncology, having authored 83 papers that have together received 2.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Immune Cell Function and Interaction (19 papers) and CAR-T cell therapy research (16 papers). The work is most often cited by research in Immunology (1.2k citations), Hematology (318 citations) and Cancer Research (350 citations). David N. Wald has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Xiaoxia Li, George R. Stark, Jinzhong Qin, Kalpana Gupta, Stephen Moreton, Marcos de Lima, Liping Tian, Jennifer E. Towne, John E. Sims and Youcun Qian. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026